Identification of KPC-2-producing Escherichia coli in a companion animal: a new challenge for veterinary clinicians
暂无分享,去创建一个
Louise Cerdeira | L. Cerdeira | M. R. Fernandes | Fábio P Sellera | Miriam R Fernandes | Regina Ruiz | Ana C M Falleiros | Fernanda P Rodrigues | Nilton Lincopan | N. Lincopán | Fábio P. Sellera | Regina Ruiz | Ana C M Falleiros
[1] E. Denamur,et al. KPC-3-producing ST167 Escherichia coli from mussels bought at a retail market in Tunisia , 2017, The Journal of antimicrobial chemotherapy.
[2] L. Wieler,et al. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence? , 2014, The Journal of antimicrobial chemotherapy.
[3] K. Bush,et al. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.
[4] J. Rolain,et al. High rates of CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in wild boars and Barbary macaques in Algeria. , 2017, Journal of global antimicrobial resistance.
[5] Sohad M. Dorgham,et al. Carbapenemase-producing Klebsiella pneumoniae in broiler poultry farming in Egypt. , 2016, Journal of global antimicrobial resistance.
[6] K. Bush,et al. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.
[7] J. Bugert,et al. Extensively Drug-Resistant New Delhi Metallo-β-Lactamase–Encoding Bacteria in the Environment, Dhaka, Bangladesh, 2012 , 2015, Emerging infectious diseases.
[8] A. Kasarskis,et al. Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli , 2017, Scientific Reports.
[9] Amy K. Cain,et al. Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting , 2017, The Journal of antimicrobial chemotherapy.
[10] P. Nordmann,et al. Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[11] B. Cao,et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[12] R. C. Picão,et al. Concentration and Variety of Carbapenemase Producers in Recreational Coastal Waters Showing Distinct Levels of Pollution , 2017, Antimicrobial Agents and Chemotherapy.